AnnJi Pharmaceutical Co., Ltd. (TPEX:7754)
Taiwan · Delayed Price · Currency is TWD 40.10
-0.20 (-0.50%)
Aug 12, 2025, 1:59 PM CST
AnnJi Pharmaceutical Company Description
AnnJi Pharmaceutical Co., Ltd. develops drugs in the therapeutic areas of neurology, dermatology, and inflammatory disorders.
It develops therapeutics, such as AJ201 for the treatment of spinal and bulbar muscular atrophy, a neurodegenerative disease; AJ202 for androgenetic alopecia; AJ302, a histone deacetylase 6 inhibitor for the prevention and treatment of chemotherapy-induced peripheral neuropathy; and AJ303, an anti-fibrotic and anti-inflammatory compound for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases.
AnnJi Pharmaceutical Co., Ltd. was founded in 2014 and is based in Taipei, Taiwan.
AnnJi Pharmaceutical Co., Ltd.
| Country | Taiwan |
| Founded | 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Wenying Huang |
Contact Details
Address: 16F.-6, No. 508, Sec. 7 Taipei, 115011 Taiwan | |
| Phone | 886 2 2365 5677 |
| Website | ajpharm.com |
Stock Details
| Ticker Symbol | 7754 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0007754004 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Wenying Huang | Chief Executive Officer |
| Lewis Yeh | Chief Financial Officer |